C45.7

Clinical Causes: Primarily related to exposure to asbestos fibers in the environment or workplace. Inhalation or ingestion of asbestos fibers leading to their accumulation in mesothelial tissues. Rare cases involving genetic predispositions or genetic mutations that increase susceptibility.

Key Symptoms: Unexplained weight loss and fatigue. Persistent chest or abdominal pain depending on the affected site. Swelling or fluid buildup in the affected area, such as the abdomen or chest. Shortness of breath or difficulty breathing if the lungs or pleural space are involved. Digestive issues like nausea, bowel changes, or swelling if the peritoneum is affected. Persistent cough or hoarseness in some cases. Loss of appetite or feeling full quickly.

Diagnosis Path: Imaging tests such as X-rays, CT scans, or MRI scans to locate tumors and assess their size and spread. Biopsy procedures to obtain tissue samples for microscopic examination, which confirm the presence of mesothelioma cells. Laboratory tests, including blood tests and analyses of pleural or peritoneal fluid if present. Advanced diagnostic techniques like PET scans to evaluate the metabolic activity of potential tumors. Staging workups to determine the extent and spread of the disease, which guides treatment options.

Treatment Protocols: Surgery to remove tumor masses may be an option in early stages. Radiation therapy to control or reduce tumor size and alleviate symptoms. Chemotherapy, utilizing drugs to kill cancer cells or slow their growth. Palliative care to manage symptoms and improve quality of life, including pain management and fluid drainage procedures. Emerging treatments like immunotherapy are being explored in clinical trials. Supportive care services such as nutritional support, physical therapy, and counseling to help cope with the disease. Participation in clinical trials for new therapies may be considered based on case specifics.